Soho House closes $1.8 billion go-private after eleventh-hour capital injection

Soho House & Co. completed its $1.8 billion take-private transaction in early May after securing late-stage funding that narrowed a closing period marked by capital uncertainty. The deal, led by existing investor Ron Burkle and a consortium including members of the company's founding management, removes the London-based membership club operator from NASDAQ after less than three years as a public company.

The transaction closed at $9.00 per share in cash, representing a 52% premium to the undisturbed trading price before merger discussions surfaced in late 2024. Stockholders approved the deal in a special meeting on May 2, with final results certified two days later. The funding gap—resolved through a combination of additional debt facilities and incremental equity commitments from the buyer group—had delayed what was initially expected to be a routine closing.

The capital structure matters because Soho House operates 43 physical locations across 11 countries, each requiring ongoing capital reinvestment in an environment where luxury hospitality development costs have climbed 18-22% since 2022. The company's private-market repositioning allows it to retreat from quarterly earnings scrutiny while pursuing a wellness-forward repositioning that CEO Andrew Carnie has described as a shift "from hedonism to health." That includes IV drip stations at select clubs and partnerships with performance-recovery brands—adjacencies that require patient capital and margin tolerance.

The timing is precise. Soho House announced board appointments concurrent with the closing, including actor and venture investor Ashton Kutcher, whose existing portfolio spans hospitality-tech and direct-to-consumer wellness brands. The signal: the new ownership structure intends to extract value through brand extensions and licensing, not unit-level EBITDA optimization. Worth noting, Soho House's 42,000 global members already skew toward media, entertainment, and venture principals—the exact cohort buying into longevity clinics and biohacking retreats.

For allocators and operators, the follow-on moves are straightforward. Watch for Soho House to announce branded residential projects in secondary European and Asian markets within six to nine months, likely structured as licensing partnerships that minimize capital deployment. Expect membership fee increases in Q3 2025, particularly for legacy members grandfathered under pre-2020 pricing. The company will likely test a tiered wellness membership add-on by year-end, monetizing the health infrastructure it has been quietly installing since late 2023.

The market for private club operators is now split. Primary residences and mega-developments are building proprietary clubs to capture ancillary revenue and resident stickiness. Standalone membership businesses like Soho House must justify $3,000-$6,000 annual dues by layering in services that feel irreplaceable—hence the pivot to medicalized wellness. The funding rescue confirms that private equity still sees margin in that arbitrage, provided the operator can execute without public-market distraction.